JPEO-CBRND RFI - Genomic Sequencing Workflows
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEPT OF DEFENSE
Contract Value
Not provided
Codes & Classification
Solicitation Number
-
NAICS
-
Classification Code
-
Additional Details
The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has issued a Special Notice in the form of a Request for Information (RFI) to gather insights from industry regarding end-to-end, untargeted genomic sequencing workflows suitable for military applications. This RFI is intended solely for information and planning purposes and does not represent a solicitation or a commitment to procure any goods or services at this stage.
The primary objective of this RFI is to survey current industry capabilities in the engineering, testing, and manufacturing of comprehensive genomic sequencing solutions that can be effectively utilized by military personnel with varying levels of technical expertise. The JPEO-CBRND, specifically the Joint Program Manager (JPM) CBRN Sensors and JPM CBRN Special Operations Forces, is seeking information on solutions that address the following key areas:
1. **Genomic Sequencing Workflows:** The government is interested in end-to-end, untargeted sequencing workflows that are appropriate for military users. These workflows should be capable of processing both environmental and clinical sample matrices. Automation of process steps is highly desirable to ensure usability in diverse operational contexts.
2. **Field-Deployable Bioinformatics Tools:** Respondents are encouraged to provide information on bioinformatics tools optimized for field deployment. These tools should be capable of detecting indicators of genetic engineering and identifying potential biological threats, regardless of their taxonomic classification.
3. **Test & Evaluation (T&E) Infrastructure:** The RFI seeks details on technologies and infrastructure that would support government-led test and evaluation of untargeted sequencing approaches, ensuring that solutions can be rigorously assessed for operational readiness.
4. **Protein Toxin Sequencing:** Capabilities for sequencing protein toxins are also of interest, including both mobile laboratory-based systems and platforms that can be deployed in the field.
Respondents are requested to submit white papers, concept briefs, and technical insights that address the design feasibility, integration pathways, operational readiness, and sustainment strategies for their proposed solutions. Ideal submissions will include a technical description of the approach, summaries of relevant experience or past performance, estimated timelines and scalability, sustainment considerations, and identification of potential cost drivers and risk factors.
This RFI is being managed by the Defense Logistics Agency (DLA Maritime), a component of the Department of Defense. The notice is currently active, with responses due no later than December 19, 2025. An Industry Day is scheduled for January 29, 2026, at the SPA, Crown Center Conference Facility, 8211 Terminal Road, Suite 1000, Lorton, VA 22079, providing an opportunity for further engagement and clarification.
Interested parties are encouraged to respond via the Joint Enterprise Technology Tool (JETT) platform by selecting “Respond to an RFI” at https://jacks.jpeocbrnd.army.mil/JETT. It is important to note that participation in this RFI is voluntary and does not preclude future participation in any subsequent solicitation, should one be issued.
No set-aside requirements or special procurement considerations are specified in this notice. Contractors should monitor the official SAM.gov listing (Opportunity ID: 050a8bca8e074f47b1c0e32a604d8b77) for any updates or additional information related to this opportunity.
This RFI represents a significant opportunity for organizations with advanced capabilities in genomic sequencing, bioinformatics, and field-deployable laboratory technologies to inform the Department of Defense’s future requirements and potential acquisition strategies in support of chemical, biological, radiological, and nuclear defense missions.